A newly identified genetic marker could potentially predict which patients are likely to respond to immunotherapy in cancer types that have lacked such tools until… Read more
Category: immunotherapy
Immunotherapy Drug is Well Tolerated in Lung Cancer Patients with Limited Physical Function, Study Suggests
For patients with advanced or metastatic non-small cell lung cancer (NSCLC) and limited performance status, an immune checkpoint inhibitor drug called durvalumab is safe and… Read more
Cancer Drug That Targets Two Immune-Evading Tumor Tactics Performs Well in Early Clinical Trial
A “two-for-one” cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scientists from UPMC Hillman Cancer Center who led an… Read more
Cancer-Infecting Virus ‘Warms Up’ Cold Tumors and Improves Immunotherapy
Equipping cancer-infecting, or oncolytic, viruses with tumor-inhibiting genetic cargo stimulates the immune system and helps immunotherapy to shrink or completely clear aggressive tumors in mice,… Read more
Pitt Study Homes in on Gut Bacteria That Help or Hurt Melanoma Treatment
A new study found that melanoma patients’ gut bacterial communities, which differ depending on a patient’s geographical region, are associated with favorable or unfavorable responses… Read more